United Kingdom

People: Suven Life Sciences Ltd (SUVP.NS)

SUVP.NS on National Stock Exchange of India

11:27am BST
Change (% chg)

Rs-0.75 (-0.31%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Jasti, Venkateswarlu 

Shri. Venkateswarlu Jasti serves as Executive Chairman of the Board, Chief Executive Officer of Suven Life Sciences Limited. He is a Post Graduate in Pharmacy from Andhra University, Visakhapatnam, and also a Post Graduate in Pharmacy from St. John University, New York, specializing in Industrial Pharmacy. Having registered himself as a Registered Pharmacist, he managed M/s Clinton Bergen Drug Company, M/s Park Way Central Pharma and M/s Kayes Drug Company, N J, USA. He was the president elect of Essex County Pharmaceutical Society of N J which no other Indian ocuupied till now. He returned from USA to India in 1988-89 and promoted this company in 1989. Since then, he been managing the company as Managing Director providing the right direction and leadership in eveloping technologies,upgrading the facilities , development of export markets etc. Mr. Jasti has been the Past President of Indian Pharmaceutical Association, and Chairman of Local Organizing Committee for the 52nd Indian Pharmaceutical Congress held at Hyderabad and was President of Bulk Drug Manufacturers Association of India (BDMA) till September, 2004. He was also the Ex-Chairman for Pharmexcil (Pharmaceutical Export Promotion Council) a statutory body for the promotion of exports of all pharma and biotech products which was set up by Govt. of India. Mr. Jasti is also the Chief architect for the formation of A.P. Chief Minister's task force for Pharma during 2001 and responsible for the creation of Pharma City at Vizag by Govt of Andhra Pradesh and Pharmexcil (Pharmaceutical Export Promotion Council) head quartered at Hyderabad by Govt of India.

Basic Compensation

Total Annual Compensation, INR 35,280,000
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR 1,740,000
Fiscal Year Total, INR 37,020,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Venkateswarlu Jasti


P. Subba Rao


K. Hanumantha Rao


Sudha Jasti


M. Gopalakrishna


Syed Hasnain

As Of  31 Mar 2015